DefiniGEN announces closing of £2.3 million ($3.8 million) Series A Fundraising
June 2, 2014
DefiniGEN Ltd, a leading provider of stem cell life science products and services, today announced the final closing of its Series A funding round. The latest £1 million ($1.6 million) placement for ordinary shares brings to a close a cumulative total for the round of £2.28 million ($3.83 million), which will support the international expansion [...]
Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
June 2, 2014
Basel -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately held company, based in Mountain View, California, USA. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia’s shareholders USD 125 million in [...]
OGT to sell Cytocell products direct in North America
June 2, 2014
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that following its acquisition of Cytocell in March, it will directly sell Cytocell products to the North American market from the 1st June 2014. New and existing Cytocell customers in North America will now benefit from OGT’s expert and experienced sales and support infrastructure, which [...]
Contract Research Organizations To Adopt Ion Torrent Next-Generation Sequencing Platform
June 2, 2014
CARLSBAD, Calif.-- Two Contract Research Organizations (CROs) with leading expertise in molecular testing have decided to utilize the new Oncomine Cancer Research panel, which runs on Life Technologies Ion Torrent sequencing instruments, for clinical trial analyses and design. This comprehensive multi-biomarker assay allows concurrent analyses of DNA and RNA in one workflow, allowing researchers to [...]
June 2, 2014
Singapore -– The National University of Singapore (NUS) Environmental Research Institute (NERI) and Shimadzu (Asia Pacific) Pte Ltd, a global leader in the manufacturing of analytical instruments, testing instruments, precision instruments, measuring instruments and medical equipment, are collaborating to conduct research on environmental contaminants. To mark this partnership, Mr Yasuo Miura, Director, Shimadzu Corporation, and [...]
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF JAMES M. O’BRIEN AS SENIOR VP, FINANCE
May 30, 2014
NEW YORK, NY -– Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biosciences and clinical laboratory company, announced today the appointment of James M. O’Brien as Senior Vice President, Finance. “Jim has an impressive professional background and brings over 15 years of experience leading and managing all financial functions for a number of diverse global organizations. [...]
May 30, 2014
CHICAGO -– Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, announced today the launch of Appistry CloudDx™, a cloud-based service for ordering genomics tests. By collecting established laboratory-developed tests (LDTs) in a single, easy-to-access environment and streamlining the processes associated with delivering clinically relevant [...]
MKS Completes Acquisition of Granville-Phillips
May 30, 2014
ANDOVER, Mass.-- MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced it has completed its acquisition of the assets of Granville-Phillips, formerly a division of Brooks Automation, Inc. (Nasdaq:BRKS), for $87 million in cash. Granville-Phillips is a leading global provider of vacuum measurement and control instruments [...]
May 30, 2014
CHICAGO -– Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, today announced an agreement with Personal Genome Diagnostics (PGDx) to include the company’s CancerSelect™ panel in Appistry’s recently released Appistry CloudDx™ genomics testing service. PGDx, a provider of CLIA-compliant genomics services to oncology researchers, [...]
May 30, 2014
HILDEN, Germany, and GERMANTOWN, Maryland -— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with Eli Lilly and Company (NYSE: LLY) to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types. The agreement includes the development [...]
